Loading clinical trials...
Loading clinical trials...
Amyloid plaques and neurofibrillary tangles are the 2 well-known etiopathological hallmarks of Alzheimer's disease (AD). Beside these 2 lesions, inflammation response is described in the brain of patients with AD. The main objective of our study is to analyse the correlation between the value of plasma cytokines (interleukin 1, 6, TNFα and chemochine Rantes) and the rapidity of the cognitive decline in AD over a 2-year follow-up. Secondary objectives include: * the predictive value of the cytokines on the cognitive decline after 6 months and one year of follow-up., of the patients include 150 patients with AD (MMSE: 16-25) * correlation between plasma cytokines levels and expression of the protein kinase PKR (involved in death cell) in blood mononuclear cells.
Age
All ages
Sex
ALL
Healthy Volunteers
No
CHU Angers - service Gérontologie clinique
Angers, France
Hôpital Dupuytren - CHU de Limoges
Limoges, France
CHU de NANTES - service Gériatrie
Nantes, France
CHU DE NANTES - Centre ambulatoire de Gérontologie clinique
Nantes, France
Hôpital Broca - service de Gériatrie
Paris, France
Hôpital Pitié Salpétrière
Paris, France
Chu de Poitiers -
Poitiers, France
Chu Strasbourg
Strasbourg, France
CHU de TOURS - service de Gériatrie
Tours, France
Hôpital gériatrique des Charpennes
Villeurbanne, France
Start Date
November 1, 2009
Primary Completion Date
November 1, 2013
Last Updated
October 11, 2016
133
ACTUAL participants
blood test and cognitive tests
OTHER
Lead Sponsor
Poitiers University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07033494